Investigating genetic factors linked to schizophrenia and bipolar disorder
Official title: Multiethnic genomic epigenomic and transcriptomic fine-mapping and functional validation analysis of schizophrenia and bipolar disorder risk loci
Funded at Icahn School of Medicine at Mount Sinai · NIH-10974473 · Data updated 2026-11-12
This study is looking at the genes that might play a role in schizophrenia and bipolar disorder to help us understand how these conditions develop, which could lead to better treatments for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | January 1, 2021 |
| Project end | October 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $1,067,884 |
| NIH project number | 5R01MH125246-05 |
| Project ID | NIH-10974473 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with schizophrenia or bipolar disorder, particularly those of diverse ethnic backgrounds.
✕Less likely to help
Patients with other psychiatric disorders or those without a diagnosis of schizophrenia or bipolar disorder may not benefit from this research.
What this research studies
This research focuses on understanding the genetic and molecular mechanisms behind schizophrenia and bipolar disorder, which are serious mental illnesses affecting many individuals. By analyzing genetic data from diverse populations, the study aims to identify specific genetic variants that contribute to these disorders. The researchers will use advanced techniques to map these variants and explore their functional roles in brain tissue. This comprehensive approach could lead to a better understanding of how these conditions develop and potentially inform future treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and targeted therapies for schizophrenia and bipolar disorder.
How similar studies have gone: Previous research has successfully identified genetic risk factors for mental illnesses using similar genomic approaches, indicating a promising avenue for this study.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Roussos, Panagiotis — Icahn School of Medicine at Mount Sinai
- Study coordinator: Roussos, Panagiotis
Related research
Other NIH-funded projects on the same topics.
-
Finding genes linked to schizophrenia and bipolar disorder in Latino and mixed-ancestry people
This project will combine genetic information and gene-activity (RNA) data from Latino people with schizophrenia, bipolar disorder, and people without these conditions to find genes that raise disease risk.
-
Identifying genetic factors for schizophrenia and bipolar disorder in diverse populations
This study is looking at how genes might play a role in schizophrenia and bipolar disorder specifically in Latino individuals, and it will involve gathering information from 1,500 people, including those with these conditions and healthy individuals, to better understand how genetics can affect mental health and treatm
-
Investigating how environmental and genetic factors contribute to schizophrenia and bipolar disorder
This study looks at how things like growing up in a city or facing tough times as a child might affect the chances of developing schizophrenia or bipolar disorder, and how these factors mix with our genes; it's designed to help us find better ways to prevent and treat these conditions.
-
Understanding social disconnection in schizophrenia using digital signals and brain data
This grant explores how smartphones, social networks, and brain imaging can reveal why Veterans with schizophrenia have trouble forming and maintaining relationships, with the goal of guiding better treatments.
-
Understanding how autism and schizophrenia risk genes affect brain development
Scientists are testing how mutations in certain autism and schizophrenia risk genes change brain cells and networks, using patient-derived cells and organoids.
-
Digital support to spread team-based schizophrenia care in primary care in India
A project to help frontline health workers in India use digital tools to provide coordinated schizophrenia care in primary care, with plans to inform care in the United States as well.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.